Saturna Capital Corp GlaxoSmithKline ADS Transaction History

Saturna Capital Corp

  • $6.54 Billion
  • Q1 2025
Number of Shares
22,650
Previous 25,200 10.12%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 02, 2025
SELL
N/A
-2,550 Reduced 10.12%
22,650 $0
Q4 2024

Feb 07, 2025
SELL
N/A
-2,138 Reduced 7.82%
25,200 $0
Q3 2024

Nov 05, 2024
BUY
N/A
1,888 Added 7.42%
27,338 $0
Q2 2024

Jul 31, 2024
SELL
N/A
-4,592 Reduced 15.29%
25,450 $0
Q1 2024

May 13, 2024
BUY
N/A
630 Added 2.14%
30,042 $0
Q4 2023

Feb 06, 2024
BUY
N/A
3,040 Added 11.53%
29,412 $0
Q3 2023

Nov 14, 2023
SELL
N/A
-1,240 Reduced 4.49%
26,372 $0
Q2 2023

Aug 04, 2023
BUY
N/A
1,659 Added 6.39%
27,612 $0
Q4 2022

Feb 09, 2023
SELL
N/A
-171,368 Reduced 86.85%
25,953 $0
Q3 2022

Nov 10, 2022
BUY
N/A
197,321 New
197,321 $5.81 Million
Track This Portfolio

Track Saturna Capital Corp Portfolio

Follow Saturna Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email